Calcichew-D3 500mg/400 IU Caplets – Pharmacy level recall
Yes – this has been recalled
- The problem
- Takeda UK Ltd are issuing a company-led drug alert for one batch of Calcichew-D3 500mg/400 IU Caplets due to traces of a non-approved excipient (CLDA (17)A/05)
- What to do
- Check the batch number on your pack against the list below. Do not stop taking a prescribed medicine without talking to your pharmacist, GP or prescriber first – they can check your supply and swap it if needed.
Source: Medicines and Healthcare products Regulatory Agency (MHRA)
Official notice ↗
Product information
CLDA number
CLDA (17)A/05
MDR number
109-11/17
Company name
Takeda UK Ltd
Product description
Calcichew-D3 500mg/400 IU Caplets
PL 16189/0027
Distributed to pharmacy level since 15 Nov 2017
Batch number/expiry
| Batch No. | Expiry date |
|---|---|
| 11372123 | May 2019 |
Brief description of the problem
The above batch is being recalled because the product has been found to contain traces of a non-approved excipient (a Patchouli-like oil) which has inadvertently been added to the lemon flavouring used in the manufacture of the tablets. Takeda has no reason to believe that the non-approved substance poses a significant risk to public health.
Company contact for stock enquiries
Alloga UK
Tel: 01773 510123
Company contact for medical information
Medical Information, Takeda UK Ltd
Tel: 01628 537900
Fax: 01628 526617
Updated 28 November 2017. This page summarises an official notice. Details can change – always follow the official notice.